Literature DB >> 9668337

Wide spectrum of symptomatic treatment in Lambert-Eaton myasthenic syndrome.

S J Oh1, D S Kim, K H Kwon, A Tseng, H Mussell, G C Claussen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9668337     DOI： 10.1111/j.1749-6632.1998.tb11025.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  2 in total

1.  Lambert-Eaton Myasthenic Syndrome.

Authors:  John Newsom-Davis
Journal:  Curr Treat Options Neurol       Date:  2001-03       Impact factor: 3.598

2.  Two Lambert-Eaton Myasthenic Syndrome Patients with Ameliorated Activities of Daily Living Due to Cholinesterase Inhibitors.

Authors:  Hiroshi Yamasaki; Naonobu Futamura; Itaru Funakawa; Nobuo Kohara; Shunsuke Yoshimura; Masakatsu Motomura
Journal:  Intern Med       Date:  2021-09-18       Impact factor: 1.271
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.